602 JOURNAL OF COSMETIC SCIENCE
MINIMUM INHIBITORY CONCENTRATION ANALYSIS
Minimum inhibitory concentration (MIC) is another effective tool used to access a
microbiome environment. This method was developed in response to issues pertaining to
the inefficiency of medical therapies to cure bacterial infections. MIC measures the in vitro
susceptibility or resistance of bacteria strains to an antibiotic, which is crucial for selecting
a therapeutic strategy to directly influence the success of infection treatment.13 MICs go a
step further than the above metagenomic sequencing. While metagenomic sequencing is
valuable for assessing the entire microbial environment, MIC testing provides a solution to
the infectious problem. With the current research of correlating certain bacteria overgrowth
on the skin to certain skin conditions, an MIC reading will provide an effective treatment
plan to restore the skin’s microbiome.
There are a few different MIC methods, including dilution (in agar or in a liquid medium)
or gradient methods (strips impregnated with a predetermined concentration gradient of
an antibiotic).13 Whichever media is chosen, within 30 minutes of preparation, the bacteria
should be added in a way that cell density is maintained. The incubation is conducted in
aerobic conditions between 18 to 24 hours. After this time, the medium is observed for any
growth of bacterial colonies. The report then states the lowest concentration of an antibiotic
in which there is no bacterial growth, the MIC.13 Figure 2 below displays an example of the
agar dilution method, one of the most used and accepted.14
Usually, multiple antibiotics are evaluated on the same bacteria to gather data at which
would be the most effective. The data is split into quantitative data (the MIC value) and
qualitative data (susceptible, intermediate, or resistant). Table I below is an example of MIC
data collected to assess the susceptibility against Klebsiella pneumoniae, a type of Gram-
negative bacteria that typically causes nosocomial infections, or infections commonly
acquired in a hospital setting.13
It is important to highlight that an alternative model was recently required due to the
growing body of evidence indicating that problematic bacterial species on the skin
frequently form biofilms. To address this, antimicrobial efficacy must be evaluated within
the context of biofilm formation, necessitating the use of a Minimum Biofilm Eradication
Figure 2. Redrawn from Giuliano.14 A quantified concentration of microorganisms on an agar plate. The
MIC is determined by identifying the lowest concentration of antibiotic that inhibits bacterial growth. This
example shows an MIC of 32 mcg/mL.14
603 SKIN MICROBIOME INNOVATIONS
Concentration (MBEC) assay for accurate assessment. This assay utilizes a Calgary Biofilm
Device for screening antibiotics and biocides for their efficacy against microbial biofilms.
This system is particularly useful for screening potential new antibiotics or biocides or
determining both the MIC and MBEC values in clinical contexts, such as treating chronic,
recurrent, or device-associated infections.15
MIC readings have proven invaluable in therapeutic treatments and are now being
integrated into the personal care industry using natural antimicrobials. For instance,
knowing the MIC value needed to inhibit C. acnes, the bacteria responsible for acne, or
Malassezia furfur, the fungus causing dandruff and seborrheic dermatitis, can guide product
development. To connect with personal care consumers, presenting a clear problem-and-
solution approach is essential: identify the microbes causing their issue, and recommend
products with ingredients that target and reduce those microbes. This method resonates
well enough with consumers, but there is a new innovative solution on the horizon that
could unify and streamline this information even further.
DERMAL MICROBIOME-IMMUNOLOGY ASSAY
With known methods of microbiome analysis that perhaps have not quite hit the mark
on effectively communicating latest information, the exciting thing about research and
uncharted landscapes is the opportunity to revolutionize the new standard for delivery.
This white space is what fueled the innovation for an assay that would allow brands to
have a pivotal role in the up-and-coming microbiome space. As previously mentioned,
dendritic cells are the sentinels of the immune system and it turns out that these cells
can easily be propagated in vitro using a multitude of growth factors, such as granulocyte
macrophage-colony stimulating factors (GM-CSF). Based on the knowledge that dendritic
cells release signals that notify the body’s immune system to start working, this new assay
Table I
Final Antibiotic Susceptibility Report for Klebsiella pneumoniae13
MIC (mcg/mL) Interpretation
Amikacin ≤2 S
Ampicillin ≥32 R
Ampicillin/Sulbactam 16 I
Cefazolin ≥64 R
Cefepime 2 R
Ceftriaxone ≥64 R
Ciprofloxacin ≥64 R
ESBL (Extended-Spectrum Beta-Lactamases) NEG
Gentamicin ≥16 R
Imipenem ≤1 S
Piperacillin ≥128 R
Piperacillin/Tazobactam 1.5 S
Tigecycline ≤0.5 S
Tobramycin 8 I
Trimethoprim/Sulfamethoxazole ≥320 R
*Redrawn from Kowalska-Krochmal.13 I: Intermediate R: Resistant
S: Susceptible.
Previous Page Next Page